
OPKO Health OPK
€ 1.27
3.15%
Quartalsbericht 2026-Q1
hinzugefügt 28.04.2026
OPKO Health P/S 2011-2026 | OPK
P/S Jährlich OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.61 | 4.09 | 0.816 | 1.14 | 2.41 | 0.977 | 2.13 | 2.4 | 3.48 | 8.18 | 55.7 | 30 | 40.7 | 52.2 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 55.7 | 0.816 | 15.1 |
P/S anderer Aktien in der Diagnostik & Forschung
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
6.64 | $ 136.85 | 1.08 % | $ 41.6 B | ||
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
9.4 | $ 8.98 | -19.75 % | $ 11.9 M | ||
|
Castle Biosciences
CSTL
|
1.37 | $ 21.18 | -4.21 % | $ 614 M | ||
|
Aspira Women's Health
AWH
|
0.37 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
0.316 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
1.63 | $ 18.59 | 1.92 % | $ 572 M | ||
|
Guardant Health
GH
|
13.7 | $ 130.04 | -2.39 % | $ 16.3 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
2.61 | $ 22.91 | 0.93 % | $ 1.22 B | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
1.23 | $ 136.98 | 0.13 % | $ 10.7 B | ||
|
Interpace Biosciences
IDXG
|
0.19 | $ 1.8 | - | $ 7.96 M | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
3.75 | $ 163.95 | 3.3 % | $ 26.1 B | ||
|
Lantheus Holdings
LNTH
|
3.32 | $ 99.51 | -0.12 % | $ 6.72 B | ||
|
Global Cord Blood Corporation
CO
|
0.244 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
19.5 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
7.06 | $ 1 173.79 | 0.88 % | $ 24.2 B | ||
|
Charles River Laboratories International
CRL
|
1.92 | $ 184.17 | 1.56 % | $ 9.13 B | ||
|
NeoGenomics
NEO
|
2.04 | $ 10.6 | 4.02 % | $ 1.36 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
National Research Corporation
NRC
|
2.29 | $ 19.95 | 1.48 % | $ 447 M | ||
|
Medpace Holdings
MEDP
|
5.12 | $ 449.68 | 0.35 % | $ 13 B | ||
|
Natera
NTRA
|
6.47 | $ 220.59 | 3.11 % | $ 21.7 B | ||
|
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
0.496 | $ 4.03 | -4.62 % | $ 373 M | ||
|
Personalis
PSNL
|
6.19 | $ 11.71 | 6.65 % | $ 1.05 B | ||
|
Koninklijke Philips N.V.
PHG
|
1.7 | $ 26.62 | 0.62 % | $ 25.2 B | ||
|
Senseonics Holdings
SENS
|
9.94 | $ 6.67 | -0.71 % | $ 278 M | ||
|
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
10.9 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
1.35 | $ 2.37 | -2.67 % | $ 5.44 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 262.33 | 0.11 % | $ 21.8 B | ||
|
Twist Bioscience Corporation
TWST
|
4.15 | $ 70.97 | 2.81 % | $ 4.24 B | ||
|
Thermo Fisher Scientific
TMO
|
4.4 | $ 493.36 | 1.27 % | $ 186 B | ||
|
Trinity Biotech plc
TRIB
|
3.15 | $ 0.72 | 1.75 % | $ 259 M | ||
|
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
1.14 | $ 9.23 | -0.75 % | $ 2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 195.88 | -0.22 % | $ 21.7 B | ||
|
Invitae Corporation
NVTA
|
4.18 | - | - | $ 21.2 M |